Spine biologics market to reach $2.72B by 2025 — 3 things to know

Written by Shayna Korol | December 03, 2018 | Print  |

The global spine biologics market is projected to grow at a 3.5 percent compound annual growth rate to reach $2.72 billion by the end of 2025, according to a Market Reports World report.

Here are three things to know:

1. North America supplies the majority of spine biologics, with nearly 63 percent of the product market share. Europe is the second largest supplier with 28 percent market share.

2. North America has a consumption market share of nearly 61 percent, and Europe has a 21 percent consumption market share.

3. Medtronic, DePuy Synthes, Stryker, Nuvasive and Zimmer Biomet are leading market players.

More articles on biologics:
Vail-Summit Orthopaedics uses injectable treatments, biologics to expand care: 3 notes
Osiris Therapeutics appoints new CEO: 3 notes
SpinalCyte earns FDA clearance for fibroblast cell therapy: 5 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months